Initially structured around enabling emerging market vaccine manufacturers to learn how to make affordable protein polysaccharide conjugates for vaccines, FinaBio is now a premier provider of conjugate vaccine laboratory and consulting services for the Biotech and Vaccine industry world-wide. Located in the heart of the Maryland biotechnology corridor, the firm offers a well-equipped laboratory for molecular biology and protein expression, conjugation, and conjugate vaccine characterization. Our scientists collaborate with universities such as Johns Hopkins and the University of Maryland, as well as the local biotechnology community to expand their resources.
